LV10042A - Dazu terapeitiski aktivu 4-aizvietotu imidazolu lietosana transdermalas iedarbibas medicinisko preperatu pagatavosanai - Google Patents

Dazu terapeitiski aktivu 4-aizvietotu imidazolu lietosana transdermalas iedarbibas medicinisko preperatu pagatavosanai

Info

Publication number
LV10042A
LV10042A LV920019A LV920019A LV10042A LV 10042 A LV10042 A LV 10042A LV 920019 A LV920019 A LV 920019A LV 920019 A LV920019 A LV 920019A LV 10042 A LV10042 A LV 10042A
Authority
LV
Latvia
Prior art keywords
pct
therapeutically active
preparation
transdermal
medicinal preparations
Prior art date
Application number
LV920019A
Other languages
English (en)
Other versions
LV10042B (en
Inventor
Harry Jalonen
Risto Arvo Sakari Lammintausta
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of LV10042A publication Critical patent/LV10042A/lv
Publication of LV10042B publication Critical patent/LV10042B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
LVP-92-19A 1991-05-31 1992-05-28 The use of certain therapeutically active 4-substituted imidazoles for the manufacture of pharmaceutical preparations to be administered transdermally LV10042B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9111773A GB2256135B (en) 1991-05-31 1991-05-31 Transdermal administration of 4-substituted imidazoles

Publications (2)

Publication Number Publication Date
LV10042A true LV10042A (lv) 1994-05-10
LV10042B LV10042B (en) 1995-02-20

Family

ID=10695905

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-92-19A LV10042B (en) 1991-05-31 1992-05-28 The use of certain therapeutically active 4-substituted imidazoles for the manufacture of pharmaceutical preparations to be administered transdermally

Country Status (18)

Country Link
US (1) US5464628A (lv)
EP (1) EP0586467B1 (lv)
JP (1) JP3269822B2 (lv)
AT (1) ATE199317T1 (lv)
AU (1) AU1780892A (lv)
CA (1) CA2110162C (lv)
DE (1) DE69231709T2 (lv)
DK (1) DK0586467T3 (lv)
EE (1) EE02994B1 (lv)
ES (1) ES2154636T3 (lv)
FI (1) FI935350A0 (lv)
GB (1) GB2256135B (lv)
GR (1) GR3035499T3 (lv)
IE (1) IE66188B1 (lv)
LT (1) LT3005B (lv)
LV (1) LV10042B (lv)
NO (1) NO307365B1 (lv)
WO (1) WO1992021334A1 (lv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997006788A1 (en) * 1995-08-14 1997-02-27 Janssen Pharmaceutica N.V. Transdermal administration of vorozole
US5891461A (en) * 1995-09-14 1999-04-06 Cygnus, Inc. Transdermal administration of olanzapine
US5807570A (en) * 1995-09-29 1998-09-15 Cygnus, Inc. Transdermal administration of ropinirole and analogs thereof
GB9614098D0 (en) 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan
DE19820151A1 (de) * 1998-05-06 1999-11-11 Hexal Ag Transdermales therapeutisches System zur Anwendung von Candesartan
TW200930291A (en) 2002-04-29 2009-07-16 Bayer Cropscience Ag Pesticidal heterocycles
FI20041425A0 (fi) * 2004-11-05 2004-11-05 Orion Corp Transmukosaalinen veterinäärinen koostumus
AU2004325626B2 (en) * 2004-12-15 2010-12-09 Drossapharm Ag External patches containing etofenamate
CA2637308C (en) 2006-01-27 2014-02-25 F. Hoffmann-La Roche Ag Use of 4-imidazole derivatives for cns disorders
US20100179205A1 (en) * 2006-08-08 2010-07-15 Intervet International B.V. Composition for Enhanced Antiparasitic Activity
US7795263B2 (en) * 2008-07-08 2010-09-14 Wildlife Laboratories, Inc. Pharmaceutical combination for and method of anesthetizing and immobilizing non-domesticated mammals
US20210323929A1 (en) * 2018-07-18 2021-10-21 Clexio Biosciences Ltd. Purified Detomidine, Process of Preparing and Methods of Use
US11185532B2 (en) 2019-05-01 2021-11-30 Clexio Biosciences Ltd. Methods of treating pruritus
CN112220767B (zh) * 2020-09-25 2022-10-25 安徽省公众检验研究院有限公司 一种盐酸阿替美唑缓释片的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518569B2 (en) * 1979-08-07 1981-10-08 Farmos-Yhtyma Oy 4-benzyl- and 4-benzoyl imidazole derivatives
GB2069481B (en) * 1980-02-13 1983-07-27 Farmos Oy Substituted imidazole derivatives
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
GB2167408B (en) 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use
US4672344A (en) 1985-04-19 1987-06-09 Siemens Aktiengesellschaft Polarized electromagnetic relay
FI864570A0 (fi) 1986-11-11 1986-11-11 Farmos Oy Terapeutiskt anvaendbar foerening.
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
FI894911A0 (fi) * 1989-10-17 1989-10-17 Farmos Oy En terapeutiskt vaerdefull foerening.
US5304569A (en) * 1989-11-13 1994-04-19 Orion-Yhtyma Oy Compositions and their use in lowering intraocular pressure

Also Published As

Publication number Publication date
AU1780892A (en) 1993-01-08
DE69231709T2 (de) 2001-10-04
ES2154636T3 (es) 2001-04-16
IE66188B1 (en) 1995-12-13
DK0586467T3 (da) 2001-03-26
IE921938A1 (en) 1992-12-02
NO934261L (no) 1993-11-25
EE02994B1 (et) 1997-06-16
NO934261D0 (no) 1993-11-25
CA2110162C (en) 2002-11-12
LTIP111A (lt) 1994-03-25
ATE199317T1 (de) 2001-03-15
JP3269822B2 (ja) 2002-04-02
FI935350A (fi) 1993-11-30
DE69231709D1 (de) 2001-04-05
NO307365B1 (no) 2000-03-27
EP0586467A1 (en) 1994-03-16
US5464628A (en) 1995-11-07
GR3035499T3 (en) 2001-06-29
EP0586467B1 (en) 2001-02-28
GB9111773D0 (en) 1991-07-24
CA2110162A1 (en) 1992-12-10
GB2256135A (en) 1992-12-02
LT3005B (lt) 1994-08-25
FI935350A0 (fi) 1993-11-30
LV10042B (en) 1995-02-20
WO1992021334A1 (en) 1992-12-10
GB2256135B (en) 1995-01-18
JPH06507618A (ja) 1994-09-01

Similar Documents

Publication Publication Date Title
LV10042A (lv) Dazu terapeitiski aktivu 4-aizvietotu imidazolu lietosana transdermalas iedarbibas medicinisko preperatu pagatavosanai
ES8107185A1 (es) Procedimiento para preparar piperidinas y pirrolidinas sus- tituidas
FI961914A0 (fi) Lyhytvaikutteiset dihydropyridiinit
HUP9801749A2 (hu) Nodulisporinsavszármazékok és az ezeket tartalmazó gyógyszerkészítmények
KR970707108A (ko) 항염증제로 유용한, 복소환부를 갖는 디-t-부틸페놀 화합물(DI-TERT-BUTYLPHENOL COMPOUNDS WITH HETEROCYCLIC MOIETY, USEFUL AS ANTI-INFLAMMATORY AGENTS)
KR930007969A (ko) 17β- 치환된 아자 - 안드로스탄 유도체
PT1044186E (pt) Composto 2-benzilamino-2-fenil-acetamida substituidos
ES8609225A1 (es) Un procedimiento para preparar un derivado de semicarbazida
ES473300A1 (es) Un procedimiento para la preparacion de una composicion cos-metica con actividad antiseborreica
KR910009259A (ko) 천식 또는 특정 피부 질환의 치료를 위한 피리미돈 유도체 및 동족체
KR940011443A (ko) 비타민 d_3-동족체
FI923759A (fi) Terapeutiska bensazapinfoereningar
ATE18221T1 (de) (1-arylcyclobutyl)(heterocyclyl)methylaminderivate, ihre herstellung und ihre verwendung als arzneimittel.
HUP9903526A2 (hu) Pirimidinszármazékok és az ezeket tartalmazó gyógyszerkészítmények
NO173057C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzanilidderivater
ME00300B (me) NOVI DERIVATI OKT AHIDR0-6, 10-DIOKS0-6N-PIRIDAZINO/l,2-a/ /l,2/DIAZEPIN-1-KARBOKSILNE KISELINE, NJIHOV POSTUPAK DOBIJANJA I NJIHOVA PRIMENA ZA DOBIJANJE TERAPEUTSKI AKTIVNIH JEDINJENJA
DE69303605D1 (de) Unverbrückte bis-aryl-carbinol-derivate, zusammensetzungen und ihre verwendung
GB1033920A (en) Novel derivatives of triphenylethanols
SE9701912D0 (sv) Pharmaceutical composition and use thereof
AU687023B2 (en) Use of idazoxan and derivatives thereof in preparing a drug for treating parkinson's disease and its development
ES8304532A1 (es) "procedimiento de preparacion de derivados de etanolamina".
KR910021373A (ko) 1-페녹시카보닐-2-피롤리디논 유도체 및 향정신성 약제
MX9709833A (es) Uso de benzimidazoles para la fabricacion de un medicamento para el tratamiento de leucemia.